Versa Vascular
Develops a transcatheter device for minimally invasive tricuspid valve repair
$42MSeries C
Role not disclosedSV
S3 Ventures
Activity from announced rounds
Activity in this selectionSeries C+
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $122M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionEndovascular Engineering
Develops thrombectomy systems for venous thromboembolism treatment
$80MSeries C
Role not disclosed